The 12th Annual Biotech in Europe Investor Forum will be highly transactional, bringing together an exciting cross-section of venture-funded and small-cap companies with leading investors, pharmas, and scientific thought leaders. Around 400 delegates and 80 presenting companies are expected.

The two-day conference programme will give you access to some of the leading players in the industry and will provide you with truly excellent networking opportunities as it boasts an online partnering system with 500 meeting slots available for all attendees to book before the event.

<p class="mainpaneltext">Read more</p>